Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?

NCT03193008 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT03193008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03193008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2017
Completion date
July 15, 2017
Enrollment
1,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer